LON:CREO Creo Medical Group (CREO) Share Price, News & Analysis → Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad) Free CREO Stock Alerts GBX 35 -0.50 (-1.41%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range 34.64▼ 35.8350-Day Range 32.50▼ 39.5052-Week Range 27.48▼ 50Volume160,396 shsAverage Volume716,459 shsMarket Capitalization£126.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get Creo Medical Group alerts: Email Address Ad Crypto 101 MediaMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. Just take a look: Claim your free seat by clicking here now. About Creo Medical Group Stock (LON:CREO)Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.Read More CREO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CREO Stock News HeadlinesMay 29, 2024 | msn.comAI Helps Medical Professionals Read Confusing EEGs to Save LivesMay 24, 2024 | finance.yahoo.comCreo Medical Group (LON:CREO) shareholders have endured a 83% loss from investing in the stock three years agoMay 15, 2024 | uk.investing.comCreo Medical confirms cash flow break-even targetMay 12, 2024 | msn.comThis 35p UK stock could rise 129%, according to a City brokerMay 8, 2024 | msn.comChepstow firm honoured with UK's top business awardMay 6, 2024 | msn.comThe Welsh firms winning the King's Awards for Enterprise 2024May 4, 2024 | msn.comThe Welsh firms winning King's Awards for Enterprise 2024May 1, 2024 | msn.comPTC (PTC) Q2 2024 Earnings Call TranscriptApril 30, 2024 | msn.comThe incredible invention made in Wales that could transform cancer careApril 24, 2024 | lse.co.ukTRADING UPDATES: ActiveOps sales up; Sancus turnover jumpsApril 24, 2024 | finance.yahoo.comCreo Medical says NHS case study reveals significant efficiencies from Speedboat technologyApril 24, 2024 | uk.investing.comCreo Medical technology leads to significant efficiencies, NHS case study findsApril 19, 2024 | bizjournals.comNew renderings released of OhioHealth Grant Medical Center's downtown expansionApril 9, 2024 | uk.finance.yahoo.comBlackRock Greater Europe Investment Trust Plc - Total Voting RightsMarch 11, 2024 | lse.co.ukGlobalworth Real Estate sells logistics portfolio for EUR70 millionMarch 11, 2024 | theglobeandmail.comVancouver readies for its position as a global pharma capital as B.C.'s biotech boom takes offFebruary 20, 2024 | bizjournals.comHouston developer picks Medical Center for next 'flexible office' outpostFebruary 17, 2024 | morningstar.comCreo Medical Group PLCFebruary 12, 2024 | finance.yahoo.comCreo Medical Group expands reach of Speedboat UltraSlim; announces tie-up with Abu Dhabi universityFebruary 12, 2024 | finance.yahoo.comCreo Medical ends "pivotal" 2023 year with clear path to cashflow breakevenFebruary 3, 2024 | msn.com10 physicians at Conemaugh Physician Group furloughedFebruary 1, 2024 | tmcnet.comCreo Engine Listed on Binance-Powered Tokocrypto, Indonesia's Leading Digital Assets PlatformJanuary 31, 2024 | lse.co.ukTRADING UPDATES: Creo unveils product in APAC; Unilever hires directorJanuary 29, 2024 | ca.finance.yahoo.comCreo Medical Group PLC (CREO.L)January 28, 2024 | finance.yahoo.comWith 67% ownership of the shares, Creo Medical Group PLC (LON:CREO) is heavily dominated by institutional ownersSee More Headlines Receive CREO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/23/2020Today6/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:CREO CUSIPN/A CIKN/A Webcreomedical.com Phone+44-1291-606005FaxN/AEmployees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-21,700,000.00 Net Margins-70.46% Pretax MarginN/A Return on Equity-39.74% Return on Assets-20.40% Debt Debt-to-Equity Ratio13.88 Current Ratio3.83 Quick Ratio2.19 Sales & Book Value Annual Sales£30.80 million Price / Sales4.11 Cash FlowGBX 14.40 per share Price / Cash Flow2.43 Book ValueGBX 17 per share Price / Book2.06Miscellaneous Outstanding Shares361,480,000Free FloatN/AMarket Cap£126.52 million OptionableNot Optionable Beta0.86 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Craig Jonathan Gulliford (Age 54)CEO & Executive Director Comp: $472.66kProf. Christopher Paul Hancock (Age 57)Founder, CTO & Executive Director Comp: $360.17kMr. Richard John Rees ACA (Age 48)CFO, Company Secretary & Executive Director Comp: $359.8kMr. David Gerard Woods (Age 59)Chief Commercial Officer & Executive Director Comp: $446.38kMr. Phil HalesSales & Marketing DirectorKey CompetitorsMaxCyteLON:MXCTNIOX GroupLON:NIOXEKF DiagnosticsLON:EKFNovacytLON:NCYTIntelligent Ultrasound GroupLON:IUGView All Competitors CREO Stock Analysis - Frequently Asked Questions How have CREO shares performed in 2024? Creo Medical Group's stock was trading at GBX 46 on January 1st, 2024. Since then, CREO stock has decreased by 23.9% and is now trading at GBX 35. View the best growth stocks for 2024 here. How were Creo Medical Group's earnings last quarter? Creo Medical Group PLC (LON:CREO) posted its quarterly earnings results on Wednesday, September, 23rd. The company reported ($6.00) EPS for the quarter. Creo Medical Group had a negative trailing twelve-month return on equity of 39.74% and a negative net margin of 70.46%. What other stocks do shareholders of Creo Medical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include MySQUAR (MYSQ) and IQE (IQE). How do I buy shares of Creo Medical Group? Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CREO) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.